These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J9098

  Injection, cytarabine liposome, 10 mg

• J9100

  Injection, cytarabine, 100 mg

• J9118

  Injection, calaspargase pegol-mknl, 10 units

• J9119

  Injection, cemiplimab-rwlc, 1 mg

• J9120

  Injection, dactinomycin, 0.5 mg

• J9130

  Dacarbazine, 100 mg

• J9144

  Injection, daratumumab, 10 mg and hyaluronidase-fihj

• J9145

  Injection, daratumumab, 10 mg

• J9150

  Injection, daunorubicin, 10 mg

• J9151

  Injection, daunorubicin citrate, liposomal formulation, 10 mg

• J9153

  Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

• J9155

  Injection, degarelix, 1 mg

• J9160

  Injection, denileukin diftitox, 300 micrograms

• J9161

  Injection, denileukin diftitox-cxdl, 1 mcg

• J9165

  Injection, diethylstilbestrol diphosphate, 250 mg

• J9171

  Injection, docetaxel, 1 mg

• J9172

  Injection, docetaxel (docivyx), 1 mg

• J9173

  Injection, durvalumab, 10 mg

• J9174

  Injection, docetaxel (beizray), 1 mg

• J9175

  Injection, elliotts' b solution, 1 ml

• J9176

  Injection, elotuzumab, 1 mg

• J9177

  Injection, enfortumab vedotin-ejfv, 0.25 mg

• J9178

  Injection, epirubicin hcl, 2 mg

• J9179

  Injection, eribulin mesylate, 0.1 mg

• J9181

  Injection, etoposide, 10 mg

• J9183

  Gemcitabine intravesical system, 225 mg

• J9184

  Injection, gemcitabine hydrochloride (avyxa), 200 mg

• J9185

  Injection, fludarabine phosphate, 50 mg

• J9190

  Injection, fluorouracil, 500 mg

• J9196

  Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg

• J9198

  Injection, gemcitabine hydrochloride, (infugem), 100 mg

• J9199

  Injection, gemcitabine hydrochloride (infugem), 200 mg

• J9200

  Injection, floxuridine, 500 mg

• J9201

  Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg

• J9202

  Goserelin acetate implant, per 3.6 mg

• J9203

  Injection, gemtuzumab ozogamicin, 0.1 mg

• J9204

  Injection, mogamulizumab-kpkc, 1 mg

• J9205

  Injection, irinotecan liposome, 1 mg

• J9206

  Injection, irinotecan, 20 mg

• J9207

  Injection, ixabepilone, 1 mg

• J9208

  Injection, ifosfamide, 1 gram

• J9209

  Injection, mesna, 200 mg

• J9210

  Injection, emapalumab-lzsg, 1 mg

• J9211

  Injection, idarubicin hydrochloride, 5 mg

• J9212

  Injection, interferon alfacon-1, recombinant, 1 microgram

• J9213

  Injection, interferon, alfa-2a, recombinant, 3 million units

• J9214

  Injection, interferon, alfa-2b, recombinant, 1 million units

• J9215

  Injection, interferon, alfa-n3, (human leukocyte derived), 250,000 iu

• J9216

  Injection, interferon, gamma 1-b, 3 million units

• J9217

  Leuprolide acetate (for depot suspension), 7.5 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.